Skip to main content
SpringerLink
Log in

Malignant Pericardial Effusion and Cardiac Tamponade (Cardiac and Pericardial Symptoms)

  • Chapter
  • First Online:
The MASCC Textbook of Cancer Supportive Care and Survivorship

  • 1284 Accesses

Abstract

A malignant pericardial effusion and a cardiac tamponade are known life-threatening complications in cancer patients. An early recognition and a prompt treatment may dramatically relieve patients of symptoms and decrease a short-term risk of death from the effusion. Although the pericardial involvement by malignancy is the leading cause, other etiological factors need exclusion before the final treatment strategy is determined. The treatment of malignant pericardial effusions must be individualized with a consideration given to the patient’s condition and tumor type, the success rates and risks of the various treatment modalities, and their local availability and expertise. The initial relief of symptoms is achieved, in most cases, with a percutaneous pericardiocentesis. A subsequent drainage of the pericardial effusion with an indwelling catheter and a local sclerotherapy and/or chemotherapy alleviates the effusion without recurrence in most of the patients. These procedures are associated with low morbidity and mortality and are preferred in the initial management of symptomatic malignant pericardial effusions. Recommended therapy for a recurrent pericardial effusion include: a repetition of pericardiocentesis and intrapericardial instillation of agents with both sclerosing and cytostatic activity, a percutaneous balloon pericardiotomy, or a surgical treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Cullinane CA, Paz IB, Smith D, et al; Prognostic factors in the surgical management of pericardial effusion in the patient with concurrent malignancy. Chest. 2004;125(4):1328–34.

    Article  PubMed  Google Scholar 

  2. Wilkes JD, Fidias P, Vaickus L, et al; Malignancy-related pericardial effusion. 127 cases from the Roswell Park Cancer Institute. Cancer. 1995;76(8):1377–87.

    CAS  Google Scholar 

  3. Marcy PY, Bondiau PY, Brunner P. Percutaneous treatment in patients presenting with malignant cardiac tamponade. Eur Radiol. 2005;15(9):2000–9.

    Article  PubMed  CAS  Google Scholar 

  4. Martinoni A, Cipolla CM, Civelli M, et al; Intrapericardial treatment of neoplastic pericardial effusions. Herz. 2000;25(8):787–93.

    Article  PubMed  CAS  Google Scholar 

  5. Murthy SC, Rozas MS, Adelstein DJ, et al; Induction chemoradiotherapy increases pleural and pericardial complications after esophagectomy for cancer. J Thorac Oncol. 2009;4(3):395–403.

    Article  PubMed  Google Scholar 

  6. Wei X, Liu HH, Tucker SL, et al; Risk factors for pericardial effusion in inoperable esophageal cancer patients treated with definitive chemoradiation therapy. Int J Radiat Oncol Biol Phys. 2008;70(3):707–14.

    Article  PubMed  Google Scholar 

  7. Dosios T, Theakos N, Angouras D, et al; Risk factors affecting the survival of patients with pericardial effusion submitted to subxiphoid pericardiostomy. Chest. 2003;124(1):242–6.

    Article  PubMed  Google Scholar 

  8. Krishnan GS, Chaudhary V, Al-Janadi A, et al; BCNU toxicity presenting with a large pericardial and pleural effusion. Ann Transplant. 2008;13(1):44–7.

    PubMed  Google Scholar 

  9. Vogl DT, Glatstein E, Carver JR, et al; Gemcitabine-induced pericardial effusion and tamponade after unblocked cardiac irradiation. Leuk Lymphoma. 2005;46(9):1313–20.

    Article  PubMed  CAS  Google Scholar 

  10. Kelly K, Swords R, Mahalingam D, et al; Serosal inflammation (pleural and pericardial effusions) related to tyrosine kinase inhibitors. Target Oncol. 2009;4(2):99–105.

    Article  PubMed  Google Scholar 

  11. Lev A, Amariglio N, Spirer Z, et al; Specific self-antigen-driven immune response in pericardial effusion as an isolated GVHD manifestation. Bone Marrow Transplant. 2010;45:1084–1087. (Epub: 2009 Nov 16).

    Google Scholar 

  12. Yonemori K, Kunitoh H, Tsuta K, et al; Prognostic factors for malignant pericardial effusion treated by pericardial drainage in solid-malignancy patients. Med Oncol. 2007;24(4):425–30.

    Article  PubMed  Google Scholar 

  13. Martinoni A, Cipolla CM, Cardinale D, et al; Long-term results of intrapericardial chemotherapeutic treatment of malignant pericardial effusions with thiotepa. Chest. 2004;126:1412–16.

    Article  PubMed  Google Scholar 

  14. Maisch B, Seferovic PM, Ristic AD, et al; Guidelines on the diagnosis and management of pericardial diseases. Executive summary. Eur Heart J. 2004;25:587–610.

    Google Scholar 

  15. Vaitkus PT, Herrmann HC, LeWinter MM. Treatment of malignant pericardial effusion. JAMA. 1994;272(1):59–64.

    Article  PubMed  CAS  Google Scholar 

  16. Dequanter D, Lothaire P, Berghmans T, et al; Severe pericardial effusion in patients with concurrent malignancy: a retrospective analysis of prognostic factors influencing survival. Ann Surg Oncol. 2008;15(11):3268–71.

    Article  PubMed  CAS  Google Scholar 

  17. Girardi LN, Ginsberg RJ, Burt ME. Pericardiocentesis and intrapericardial sclerosis: effective therapy for malignant pericardial effusions. Ann Thorac Surg. 1997;64:1422–28.

    Article  PubMed  CAS  Google Scholar 

  18. Swanson N, Mirza I, Wijesinghe N. Primary percutaneous balloon pericardiotomy for malignant pericardial effusion. Catheter Cardiovasc Interv. 2008;71(4):504–7.

    Article  PubMed  Google Scholar 

  19. Kunitoh H, Tamura T, Shibata T, et al; A randomised trial of intrapericardial bleomycin for malignant pericardial effusion with lung cancer (JCOG9811). Br J Cancer. 2009;100(3):464–9.

    Article  PubMed  CAS  Google Scholar 

  20. Tomkowski WZ, Filipecki S. Intrapericardial cisplatin for the management of patients with large malignant pericardial effusion in the course of the lung cancer. Lung Cancer. 1997;16(2–3):215–22.

    Article  PubMed  CAS  Google Scholar 

  21. Moriya T, Takiguchi Y, Tabeta H, et al; Controlling malignant pericardial effusion by intrapericardial carboplatin administration in patients with primary non-small-cell lung cancer. Br J Cancer. 2000;83(7):858–62.

    Article  PubMed  CAS  Google Scholar 

  22. Gross JL, Younes RN, Deheinzelin D, et al; Surgical management of symptomatic pericardial effusion in patients with solid malignancies. Ann Surg Oncol. 2006;13(12):1732–8.

    Article  PubMed  Google Scholar 

  23. Shimizu S, Yajima M, Yoshii A, et al; Malignant pericardial effusion and cardiac tamponade originating from uterine carcinosarcoma. Arch Gynecol Obstet. 2009;279(3):373–5.

    Article  PubMed  Google Scholar 

  24. Nojiri S, Yumino Y, Sato K, et al; A case of pericardial malignant mesothelioma accompanied by primary lung adenocarcinoma. Nihon Kokyuki Gakkai Zasshi. 2009;47(2):104–9.

    PubMed  Google Scholar 

  25. Petersen EE, Shamshirsaz AA, Brennan TM, et al; Malignant pericardial effusion with cardiac tamponade in ovarian adenocarcinoma. Arch Gynecol Obstet. 2009;280(4):675–8.

    Article  PubMed  Google Scholar 

  26. Laham RJ, Cohen DJ, Kuntz RE, et al; Pericardial effusion in patients with cancer: outcome with contemporary management strategies. Heart. 1996;75(1):67–71.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Center, Zluty kopec 7, Brno, 65653, Czech Republic

    Marek Svoboda

Authors
  1. Marek Svoboda
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Marek Svoboda .

Editor information

Editors and Affiliations

  1. Clinical Professor, Cancer Coucil Australia, University of Sydney Medical School, Surry Hills, 2010, New South Wales, Australia

    Ian N. Olver

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Society for Imaging Informatics in Medicine

About this chapter

Cite this chapter

Svoboda, M. (2010). Malignant Pericardial Effusion and Cardiac Tamponade (Cardiac and Pericardial Symptoms). In: Olver, I. (eds) The MASCC Textbook of Cancer Supportive Care and Survivorship. Springer, Boston, MA. https://doi.org/10.1007/978-1-4419-1225-1_9

Download citation

  • DOI: https://doi.org/10.1007/978-1-4419-1225-1_9

  • Published:

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4419-1224-4

  • Online ISBN: 978-1-4419-1225-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation